{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:45:43Z","timestamp":1768261543158,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T00:00:00Z","timestamp":1300752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00428-011-1062-5","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T10:18:08Z","timestamp":1300702688000},"page":"571-581","source":"Crossref","is-referenced-by-count":8,"title":["EGFR\/erB-1, HER2\/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study"],"prefix":"10.1007","volume":"458","author":[{"given":"V\u00edtor","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Joana Esp\u00edrito","family":"Santo","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Cabral","sequence":"additional","affiliation":[]},{"given":"Ana Maria","family":"Alarc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Couceiro","sequence":"additional","affiliation":[]},{"given":"Lina","family":"Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jnci\/66.6.1192","volume":"66","author":"R Doll","year":"1981","unstructured":"Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191\u20131308","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 8","key":"1062_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2307\/3432300","volume":"103","author":"DR Shopland","year":"1995","unstructured":"Shopland DR (1995) Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 103(Suppl 8):131\u2013142","journal-title":"Environ. Health Perspect."},{"key":"1062_CR3","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.109.3_Supplement.14S","volume":"109","author":"TR Devereux","year":"1996","unstructured":"Devereux TR, Taylor JA, Barrett JC (1996) Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Giles F. Filley Lecture. Chest 109:14S\u201319S","journal-title":"Chest"},{"key":"1062_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","volume":"53","author":"A Jemal","year":"2003","unstructured":"Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53:5\u201326","journal-title":"CA Cancer J Clin"},{"key":"1062_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/annonc\/mdh051","volume":"15","author":"RC Winterhalder","year":"2004","unstructured":"Winterhalder RC, Hirsch FR, Kotantoulas GK, Franklin WA, Bunn PA Jr (2004) Chemoprevention of lung cancer\u2014from biology to clinical reality. Ann Oncol 15:185\u2013196","journal-title":"Ann Oncol"},{"key":"1062_CR6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1183\/09031936.02.00296502","volume":"20","author":"AP Meert","year":"2002","unstructured":"Meert AP, Martin B, Delmotte P, Berghmans T, Lafitte JJ, Mascaux C et al (2002) The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 20:975\u2013981","journal-title":"Eur Respir J"},{"key":"1062_CR7","first-page":"5813","volume":"9","author":"RS Herbst","year":"2003","unstructured":"Herbst RS, Bunn PA Jr (2003) Targeting the epidermal growth factor receptor in non-small cell lung cancer. Clin Cancer Res 9:5813\u20135824","journal-title":"Clin Cancer Res"},{"key":"1062_CR8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jnci\/dji055","volume":"97","author":"H Shigematsu","year":"2005","unstructured":"Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II et al (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97:339\u2013346","journal-title":"J Natl Cancer Inst"},{"key":"1062_CR9","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-60049-4","volume-title":"Histological Classification of Lung and Pleural Tumors","author":"WD Travis","year":"1999","unstructured":"Travis WD (1999) Histological Classification of Lung and Pleural Tumors. International Histological Classification of Tumors, Berlin, PA"},{"key":"1062_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJM195701172560301","volume":"256","author":"O Auerbach","year":"1957","unstructured":"Auerbach O, Forman JB, Gere JB, Kassouny DY, Muehsam GE, Petrick TG et al (1957) Changes in the bronchial epithelium in relation to smoking and cancer of the lung; a report of progress. N Engl J Med 256:97\u2013104","journal-title":"N Engl J Med"},{"key":"1062_CR11","volume-title":"Lung Tumours. Fundamental Biology and Clinical Management (pp. 61\u201387)","author":"TV Colby","year":"1999","unstructured":"Colby TV (1999) Precursor lesions to pulmonary neoplasia. In: Brambilla C, Brambilla E (eds) Lung Tumours. Fundamental Biology and Clinical Management (pp. 61\u201387). Marcel Dekker Inc, New York, PA"},{"key":"1062_CR12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.onc.1202349","volume":"18","author":"II Wistuba","year":"1999","unstructured":"Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD et al (1999) Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18:643\u2013650","journal-title":"Oncogene"},{"key":"1062_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005382-200001000-00003","volume":"15","author":"WA Franklin","year":"2000","unstructured":"Franklin WA (2000) Pathology of lung cancer. J Thorac Imaging 15:3\u201312","journal-title":"J Thorac Imaging"},{"key":"1062_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.123.1.181","volume":"123","author":"CJ Piyathilake","year":"2003","unstructured":"Piyathilake CJ, Frost AR, Manne U, Weiss H, Heimburger DC, Grizzle WE (2003) Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers. Chest 123:181\u2013186","journal-title":"Chest"},{"issue":"Suppl 3","key":"1062_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.8-suppl_3-5","volume":"8","author":"EK Rowinsky","year":"2003","unstructured":"Rowinsky EK (2003) Signal events: cell signal transduction and its inhibition in cancer. Oncologist 8(Suppl 3):5\u201317","journal-title":"Oncologist"},{"key":"1062_CR16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1378\/chest.103.5.1429","volume":"103","author":"EJ Peters","year":"1993","unstructured":"Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS et al (1993) Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103:1429\u20131432","journal-title":"Chest"},{"key":"1062_CR17","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","volume":"21","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Varella-Garcia M, Bunn PA Jr, Di Maria MV, Veve R, Bremmes RM et al (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 21:3798\u20133807","journal-title":"J Clin Oncol"},{"key":"1062_CR18","doi-asserted-by":"crossref","first-page":"130S","DOI":"10.1378\/chest.109.5_Supplement.130S","volume":"109","author":"G Giaccone","year":"1996","unstructured":"Giaccone G (1996) Oncogenes and antioncogenes in lung tumorigenesis. Chest 109:130S\u2013134S","journal-title":"Chest"},{"key":"1062_CR19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0022-5223(99)70121-2","volume":"118","author":"KM Fong","year":"1999","unstructured":"Fong KM, Sekido Y, Minna JD (1999) Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg 118:1136\u20131152","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1062_CR20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/carcin\/20.8.1403","volume":"20","author":"T Kohno","year":"1999","unstructured":"Kohno T, Yokota J (1999) How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis 20:1403\u20131410","journal-title":"Carcinogenesis"},{"key":"1062_CR21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1183\/09031936.03.00064902","volume":"21","author":"AP Meert","year":"2003","unstructured":"Meert AP, Verdebout JM, Martin B, Ninane V, Feoli F, Sculier JP (2003) Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions. Eur Respir J 21:611\u2013615","journal-title":"Eur Respir J"},{"key":"1062_CR22","first-page":"296","volume":"144","author":"T Hirano","year":"1994","unstructured":"Hirano T, Franzen B, Kato H, Ebihara Y, Auer G (1994) Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression. Am J Pathol 144:296\u2013302","journal-title":"Am J Pathol"},{"key":"1062_CR23","first-page":"303","volume":"144","author":"ZH Li","year":"1994","unstructured":"Li ZH, Zheng J, Weiss LM, Shibata D (1994) c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144:303\u2013309","journal-title":"Am J Pathol"},{"key":"1062_CR24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/bjc.1997.300","volume":"75","author":"DC Betticher","year":"1997","unstructured":"Betticher DC, Heighway J, Thatcher N, Hasleton PS (1997) Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients. Br J Cancer 75:1761\u20131768","journal-title":"Br J Cancer"},{"key":"1062_CR25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/bjc.1997.121","volume":"75","author":"Y Satoh","year":"1997","unstructured":"Satoh Y, Ishikawa Y, Nakagawa K, Hirano T, Tsuchiya E (1997) A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers. Br J Cancer 75:678\u2013683","journal-title":"Br J Cancer"},{"key":"1062_CR26","first-page":"1609","volume":"4","author":"E Brambilla","year":"1998","unstructured":"Brambilla E, Gazzeri S, Lantuejoul S, Coll JL, Moro D, Negoescu A et al (1998) p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer. Clin Cancer Res 4:1609\u20131618","journal-title":"Clin Cancer Res"},{"key":"1062_CR27","first-page":"5811","volume":"54","author":"K Sugio","year":"1994","unstructured":"Sugio K, Kishimoto Y, Virmani AK, Hung JY, Gazdar AF (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res 54:5811\u20135815","journal-title":"Cancer Res"},{"key":"1062_CR28","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1001\/jama.273.24.1908","volume":"273","author":"J Hung","year":"1995","unstructured":"Hung J, Kishimoto Y, Sugio K, Virmani A, McIntire DD, Minna JD et al (1995) Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:1908","journal-title":"JAMA"},{"key":"1062_CR29","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jnci\/87.16.1224","volume":"87","author":"Y Kishimoto","year":"1995","unstructured":"Kishimoto Y, Sugio K, Hung JY, Virmani AK, McIntire DD, Minna JD et al (1995) Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87:1224\u20131229","journal-title":"J Natl Cancer Inst"},{"key":"1062_CR30","first-page":"1973","volume":"59","author":"II Wistuba","year":"1999","unstructured":"Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S et al (1999) Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 59:1973\u20131979","journal-title":"Cancer Res"},{"key":"1062_CR31","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/89.18.1366","volume":"89","author":"II Wistuba","year":"1997","unstructured":"Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J et al (1997) Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366\u20131373","journal-title":"J Natl Cancer Inst"},{"key":"1062_CR32","unstructured":"Franklin WA, Wistuba II, Geisinger K, Lam S, Hirsh FR (2004) Squamous dysplasia and carcinoma in situ. In Travis WD, Brambilla E, M\u00fcller-Hermelink HK, & Harris CK (Eds.) Tumours of the lung, pleura, thymus and heart. Pathology and genetics. pp. 68\u201372. Lyon, PA: IARC Press"},{"key":"1062_CR33","first-page":"1030","volume":"46","author":"CM Stoscheck","year":"1986","unstructured":"Stoscheck CM, King LE Jr (1986) Role of epidermal growth factor in carcinogenesis. Cancer Res 46:1030\u20131037","journal-title":"Cancer Res"},{"key":"1062_CR34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/path.1711520408","volume":"152","author":"MS Berger","year":"1987","unstructured":"Berger MS, Gullick WJ, Greenfield C, Evans S, Addis BJ, Waterfield MD (1987) Epidermal growth factor receptors in lung tumours. J Pathol 152:297\u2013307","journal-title":"J Pathol"},{"key":"1062_CR35","first-page":"403","volume":"79","author":"RE Sobol","year":"1987","unstructured":"Sobol RE, Astarita RW, Hofeditz C, Masui H, Fairshter R, Royston I et al (1987) Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J Natl Cancer Inst 79:403\u2013407","journal-title":"J Natl Cancer Inst"},{"key":"1062_CR36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/erc.0.0080011","volume":"8","author":"N Prenzel","year":"2001","unstructured":"Prenzel N, Fischer OM, Streit S, Hart S, Ullrich A (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr Relat Cancer 8:11\u201331","journal-title":"Endocr. Relat Cancer"},{"key":"1062_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127\u2013137","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1062_CR38","first-page":"734","volume":"8","author":"CJ Piyathilake","year":"2002","unstructured":"Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC et al (2002) Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 8:734\u2013744","journal-title":"Clin Cancer Res"},{"key":"1062_CR39","first-page":"2379","volume":"53","author":"V Rusch","year":"1993","unstructured":"Rusch V, Baselga J, Cordon-Cardo C, Orazem ZM, Hoda S et al (1993) Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 53:2379\u20132385","journal-title":"Cancer Res"},{"key":"1062_CR40","first-page":"1787","volume":"2","author":"JM Kurie","year":"1996","unstructured":"Kurie JM, Shin HJ, Lee JS, Morice RC, Ro JY, Lippman SM et al (1996) Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res 2:1787\u20131793","journal-title":"Clin Cancer Res"},{"key":"1062_CR41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.31520","volume":"29","author":"WA Franklin","year":"2002","unstructured":"Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr (2002) Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 29:3\u201314","journal-title":"Semin Oncol"},{"key":"1062_CR42","first-page":"54","volume":"8","author":"F Lonardo","year":"2002","unstructured":"Lonardo F, Dragnev KH, Freemantle SJ, Ma Y, Memoli N, Sekula D et al (2002) Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. Clin Cancer Res 8:54\u201360","journal-title":"Clin Cancer Res"},{"key":"1062_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/sonc.2002.31523","volume":"29","author":"FR Hirsch","year":"2002","unstructured":"Hirsch FR, Franklin WA, Veve R, Varella-Garcia M, Bunn PA Jr (2002) HER2\/neu expression in malignant lung tumors. Semin Oncol 29:51\u201358","journal-title":"Semin Oncol"},{"key":"1062_CR44","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1074\/jbc.271.11.6071","volume":"271","author":"RR Beerli","year":"1996","unstructured":"Beerli RR, Hynes NE (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem 271:6071\u20136076","journal-title":"J Biol Chem"},{"key":"1062_CR45","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1002\/j.1460-2075.1996.tb00603.x","volume":"15","author":"R Pinkas-Kramarski","year":"1996","unstructured":"Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L et al (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15:2452\u20132467","journal-title":"EMBO J"},{"key":"1062_CR46","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/emboj\/16.7.1647","volume":"16","author":"D Graus-Porta","year":"1997","unstructured":"Graus-Porta D, Beerli RR, Daly JM, Hynes NE (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16:1647\u20131655","journal-title":"EMBO J"},{"key":"1062_CR47","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-5223(94)70107-5","volume":"107","author":"PF Bongiorno","year":"1994","unstructured":"Bongiorno PF, Whyte RI, Lesser EJ, Moore JH, Orringer MB, Beer DG (1994) Alterations of K-ras, p53, and erbB-2\/neu in human lung adenocarcinomas. J Thorac Cardiovasc Surg 107:590\u2013595","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1062_CR48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0960-7404(94)90006-X","volume":"3","author":"M Tateishi","year":"1994","unstructured":"Tateishi M, Ishida T, Kohdono S, Hamatake M, Fukuyama Y, Sugimachi K (1994) Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma. Surg Oncol 3:109\u2013113","journal-title":"Surg Oncol"},{"key":"1062_CR49","first-page":"1850","volume":"7","author":"J Brabender","year":"2001","unstructured":"Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D et al (2001) Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin Cancer Res 7:1850\u20131855","journal-title":"Clin Cancer Res"},{"key":"1062_CR50","first-page":"3239","volume":"7","author":"PA Bunn Jr","year":"2001","unstructured":"Bunn PA Jr, Helfrich B, Soriano AF, Franklin WA, Varella-Garcia M, Hirsch FR et al (2001) Expression of Her-2\/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents. Clin Cancer Res 7:3239\u20133250","journal-title":"Clin Cancer Res"},{"key":"1062_CR51","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/S0003-4975(01)03207-6","volume":"72","author":"WW Lai","year":"2001","unstructured":"Lai WW, Chen FF, Wu MH, Chow NH, Su WC, Ma MC et al (2001) Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer. Ann Thorac Surg 72:1868\u20131876","journal-title":"Ann Thorac Surg"},{"issue":"Suppl 1","key":"1062_CR52","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.3816\/CLC.2003.s.014","volume":"5","author":"FR Khuri","year":"2003","unstructured":"Khuri FR (2003) Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention. Clin Lung Cancer 5(Suppl 1):S36\u2013S40","journal-title":"Clin Lung Cancer"},{"key":"1062_CR53","doi-asserted-by":"crossref","first-page":"4249s","DOI":"10.1158\/1078-0432.CCR-040019","volume":"10","author":"FR Khuri","year":"2004","unstructured":"Khuri FR, Cohen V (2004) Molecularly targeted approaches to the chemoprevention of lung cancer. Clin Cancer Res 10:4249s\u20134253s","journal-title":"Clin Cancer Res"},{"key":"1062_CR54","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1200\/JCO.2005.14.209","volume":"23","author":"FR Hirsch","year":"2005","unstructured":"Hirsch FR, Lippman SM (2005) Advances in the biology of lung cancer chemoprevention. J Clin Oncol 23:3186\u20133197","journal-title":"J Clin Oncol"},{"key":"1062_CR55","first-page":"2005","volume":"25","author":"AP Meert","year":"2005","unstructured":"Meert AP, Martin B, Verdebout JM, Ninane V, Sculier JP (2005) Does c-erbB-2 play a role in the first steps of lung carcinogenesis? Anticancer Res 25:2005\u20132008","journal-title":"Anticancer Res"},{"key":"1062_CR56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3816\/CLC.2005.n.023","volume":"7","author":"NF Saba","year":"2005","unstructured":"Saba NF, Khuri FR (2005) Chemoprevention strategies for patients with lung cancer in the context of screening. Clin Lung Cancer 7:92\u201399","journal-title":"Clin Lung Cancer"},{"key":"1062_CR57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/jnci\/dji112","volume":"97","author":"F Cappuzzo","year":"2005","unstructured":"Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L et al (2005) Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 97:643\u2013655","journal-title":"J Natl Cancer Inst"},{"key":"1062_CR58","first-page":"2195","volume":"9","author":"M Jeanmart","year":"2003","unstructured":"Jeanmart M, Lantuejoul S, Fievet F, Moro D, Sturm N, Brambilla C et al (2003) Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin Cancer Res 9:2195\u20132203","journal-title":"Clin Cancer Res"},{"key":"1062_CR59","first-page":"135","volume":"26","author":"AP Meert","year":"2006","unstructured":"Meert AP, Martin B, Verdebout JM, Feoli F, Mascaux C, Ninane V et al (2006) EGFR, c-erbB-2 and ki-67 in NSCLC and preneoplastic bronchial lesions. Anticancer Res 26:135\u2013138","journal-title":"Anticancer Res"},{"key":"1062_CR60","doi-asserted-by":"crossref","first-page":"4227s","DOI":"10.1158\/1078-0432.CCR-040007","volume":"10","author":"GV Scagliotti","year":"2004","unstructured":"Scagliotti GV, Selvaggi G, Novello S, Hirsch FR (2004) The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res 10:4227s\u20134232s","journal-title":"Clin Cancer Res"},{"key":"1062_CR61","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1369\/jhc.3A6195.2004","volume":"52","author":"D Atkins","year":"2004","unstructured":"Atkins D, ReiffenKA TCL, Winther H, Bonato MS, Storkel S (2004) Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52:893\u2013901","journal-title":"J Histochem Cytochem"},{"key":"1062_CR62","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/1078-0432.CCR-0373-3","volume":"10","author":"A Onn","year":"2004","unstructured":"Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD et al (2004) Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 10:136\u2013143","journal-title":"Clin Cancer Res"},{"key":"1062_CR63","first-page":"3819","volume":"16","author":"A Giatromanolaki","year":"1996","unstructured":"Giatromanolaki A, Koukourakis MI, O'Byrne K, Kaklamanis L, Dicoglou C, Trichia E et al (1996) Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res 16:3819\u20133825","journal-title":"Anticancer Res"},{"key":"1062_CR64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1183\/09031936.00.16599100","volume":"16","author":"N Reinmuth","year":"2000","unstructured":"Reinmuth N, Brandt B, Kunze WP, Junker K, Thomas M, Achatzy R et al (2000) Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J 16:991\u2013996","journal-title":"Eur Respir J"},{"key":"1062_CR65","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3727\/096504003108748348","volume":"13","author":"T Kanematsu","year":"2003","unstructured":"Kanematsu T, Yano S, Uehara H, Bando Y, Sone S (2003) Phosphorylation, but not overexpression, of epidermal growth factor receptor is associated with poor prognosis of non-small cell lung cancer patients. Oncol Res 13:289\u2013298","journal-title":"Oncol Res"},{"key":"1062_CR66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2559.2004.01748.x","volume":"44","author":"AP Meert","year":"2004","unstructured":"Meert AP, Feoli F, Martin B, Verdebout JM, Mascaux C, Verhest A et al (2004) Ki67 expression in bronchial preneoplastic lesions and carcinoma in situ defined according to the new 1999 WHO\/IASLC criteria: a preliminary study. Histopathology 44:47\u201353","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"1062_CR67","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0169-5002(03)00137-5","volume":"41","author":"FR Hirsch","year":"2003","unstructured":"Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA (2003) Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies. Lung Cancer 41(Suppl 1):S29\u2013S42","journal-title":"Lung Cancer"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-011-1062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-011-1062-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T13:01:56Z","timestamp":1592398916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-011-1062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,22]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1007\/s00428-011-1062-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,22]]}}}